Get the Stockscreener App
86.39
7.22%
5.82
Agilon Health Inc stock is traded at $86.39, with a volume of 336.00K.
It is up +7.22% in the last 24 hours and up +205.05% over the past month.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
See More
Previous Close:
$80.57
Open:
$81.8
24h Volume:
336.00K
Relative Volume:
0.86
Market Cap:
$1.44B
Revenue:
$5.93B
Net Income/Loss:
$-405.35M
P/E Ratio:
-3.5484
EPS:
-24.3461
Net Cash Flow:
$-148.87M
1W Performance:
+5.70%
1M Performance:
+205.05%
6M Performance:
+456.10%
1Y Performance:
+57.07%
1-Day Range:
$74.55
$87.02
1-Week Range:
$74.55
$90.48
52-Week Range:
$7.48
$90.48
Agilon Health Inc Stock (AGL) Company Profile
Name
Agilon Health Inc
Sector
Industry
Phone
562-256-3800
Address
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
86.39 | 1.34B | 5.93B | -405.35M | -148.87M | -24.35 |
HCA
Hca Healthcare Inc
|
394.07 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
173.78 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.52 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.96 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-10-25 | Upgrade | Citigroup | Sell → Neutral |
| Jan-10-25 | Initiated | Needham | Hold |
| Dec-16-24 | Initiated | Macquarie | Neutral |
| Dec-11-24 | Initiated | Bernstein | Mkt Perform |
| Nov-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-30-24 | Downgrade | Citigroup | Neutral → Sell |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Apr-22-24 | Initiated | Citigroup | Neutral |
| Mar-06-24 | Initiated | Barclays | Underweight |
| Feb-26-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-26-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Stifel | Buy → Hold |
| Jan-08-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-05-24 | Downgrade | Truist | Buy → Hold |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-21-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-23 | Initiated | The Benchmark Company | Buy |
| Jun-13-23 | Initiated | Evercore ISI | In-line |
| Dec-09-22 | Initiated | Stifel | Buy |
| Sep-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-12-22 | Initiated | Goldman | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| Jun-24-22 | Initiated | BTIG Research | Neutral |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Oct-20-21 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| May-11-21 | Initiated | William Blair | Outperform |
| May-10-21 | Initiated | BofA Securities | Buy |
| May-10-21 | Initiated | Deutsche Bank | Buy |
| May-10-21 | Initiated | Goldman | Buy |
| May-10-21 | Initiated | JP Morgan | Overweight |
| May-10-21 | Initiated | Truist | Buy |
| May-10-21 | Initiated | Wells Fargo | Overweight |
| May-10-21 | Initiated | Wolfe Research | Outperform |
View All
Agilon Health Inc Stock (AGL) Latest News
7 Small-Cap Stocks More Than Doubled In May: Micron Did Only 46% - Benzinga
Agilon Health Analyst Ratings and Price Targets | NYSE:AGL - Benzinga
Benchmark Co. Maintains Agilon Health(AGL.US) With Buy Rating, Raises Target Price to $95 - Moomoo
Q1 Earnings Highs And Lows: Select Medical (NYSE:SEM) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo! Finance Canada
AGL Maintained by Benchmark -- Price Target Lowered to $95.00 - GuruFocus
Agilon Health (AGL) Appoints Tim O’Rourke as Chief Executive Officer - Insider Monkey
Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Sahm
Dow Dips 350 Points; US Foods Posts Downbeat Earnings - Sahm
Top 2 Health Care Stocks That May Plunge This Month - Benzinga
Agilon Health’s SWOT analysis: stock faces profitability pressures By Investing.com - Investing.com South Africa
Agilon Health’s SWOT analysis: stock faces profitability pressures - Investing.com
Leerink raises agilon health stock price target to $92 on cost trends By Investing.com - Investing.com South Africa
Agilon Health (AGL) Gets a Hold from Truist Financial - The Globe and Mail
Leerink raises agilon health stock price target to $92 on cost trends - Investing.com Nigeria
Truist reiterates Hold on agilon health stock with $67 target - Investing.com UK
Truist reiterates Hold on agilon health stock with $67 target By Investing.com - Investing.com South Africa
What's going on with Agilon Health stock Friday? - MSN
Agilon Health Q1 2026 Results: Revenue Beat, EBITDA Surge, and Full-Year Outlook RaisedNews and Statistics - IndexBox
5 Revealing Analyst Questions From agilon health’s Q1 Earnings Call - Yahoo Finance
AGL Maintains Rating by Citigroup -- Price Target Raised to $80. - GuruFocus
Agilon Health Is Maintained at Neutral by Citigroup - Moomoo
Bernstein raises Agilon Health stock price target on improved results - Investing.com India
NYSE New 52-Week Highs And Lows - Moomoo
Agilon Health Price Target Raised to $80.00/Share From $18.75 by Citigroup - Moomoo
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $80 - Moomoo
Bernstein raises Agilon Health stock price target on improved results By Investing.com - Investing.com Nigeria
Agilon Health (AGL) price target increased by 50.63% to 30.22 - MSN
AQR Holdings reports 974,897-share, 5.87% stake in agilon health (AGL) - Stock Titan
Agilon Health stock reaches 52-week high at 72.48 USD By Investing.com - Investing.com South Africa
Agilon Health stock reaches 52-week high at 72.48 USD - Investing.com
Goldman Sachs (NYSE: GS) discloses 1.02M-share, 6.1% stake in Agilon Health - Stock Titan
agilon health (AGL) Q1 2026 Earnings Transcript - AOL.com
A Look At Agilon Health (AGL) Valuation After Strong Q1 Profitability And Raised 2026 Sales Guidance - Yahoo Finance
Earnings call transcript: Agilon Health’s Q1 2026 EPS Surges Past Expectations - Investing.com Nigeria
Earnings call transcript: Agilon Health’s Q1 2026 EPS Surges Past Expectations By Investing.com - Investing.com South Africa
Agilon Health Inc Stock (AGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.74%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):